Expert Opinion on Drug Safety, Volume 23, Issue 5 (2024)

Browse this journal

Expert Opinion on Drug Safety, Volume 23, Issue 5 (2024)

See all volumes and issues
Volume 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S. McIntyre
Pages: 539-542
Published online: 26 Mar 2024
First Page PreviewforGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas | Full Text | References | PDF (196.4 KB) | EPUB
  • 1231 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Adverse drug event reporting among women: uncovering disparities in underserved communities
Ahmad Z. Al Meslamani
Pages: 543-545
Published online: 30 Mar 2024
First Page PreviewforAdverse drug event reporting among women: uncovering disparities in underserved communities | Full Text | References | PDF (154.6 KB) | EPUB
  • 111 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Perspective

Comment
Learning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels
Harriet Dickinson, Jan Feifel, Katoo Muylle, Taichi Ochi & Enriqueta Vallejo-Yagüe
Pages: 547-552
Published online: 06 May 2024
AbstractforLearning with an evolving medicine label: how artificial intelligence-based medication recommendation systems must adapt to changing medication labels | Full Text | References | PDF (293.2 KB) | EPUB
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Safety profile of Helicobacter pylori eradication treatments: literature review and updated data of the European Registry on Helicobacter pylori management (Hp-EuReg)
Irina Luzko, Olga P. Nyssen, Leticia Moreira & Javier P. Gisbert
Pages: 553-564
Published online: 03 Apr 2024
AbstractforSafety profile of Helicobacter pylori eradication treatments: literature review and updated data of the European Registry on Helicobacter pylori management (Hp-EuReg) | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 56 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis
Giovanni Corona, Giulia Rastrelli, Clotilde Sparano, Valeria Carinci, Gianni Casella, Linda Vignozzi, Alessandra Sforza & Mario Maggi
Pages: 565-579
Published online: 06 May 2024
AbstractforCardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis | Full Text | References | PDF (779.5 KB) | EPUB | Supplemental
  • 69 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
A real‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab
Xiaolin Yun, Yingying Zhou, Danna Wu, Yuanbo Liu & Qiongshi Wu
Pages: 581-591
Published online: 10 Apr 2024
AbstractforA real‑world pharmacovigilance study of FDA adverse event reporting system events for daratumumab | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 72 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
An observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity
Khushboo Bisht, Bharathi Mohan, Basavaraj Jatteppanavar, Hannah Theresa Sony, Shailendra Handu & Minakshi Dhar
Pages: 593-597
Published online: 04 Apr 2024
AbstractforAn observational study of root-cause analysis of medication errors in elderly with methotrexate toxicity | Full Text | References | PDF (686.4 KB) | EPUB | Supplemental
  • 65 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Adverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System
Dehua Zhao, Xiaoqing Long & Jisheng Wang
Pages: 599-605
Published online: 01 Apr 2024
AbstractforAdverse events with pemigatinib in the real world: a pharmacovigilance study based on the FDA Adverse Event Reporting System | Full Text | References | PDF (477.3 KB) | EPUB | Supplemental
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Analysis of drug-induced posterior reversible encephalopathy syndrome using the food and drug administration adverse drug events reporting system database
Cai-Lu Lei, Xiao-Long Gui, Lin-Yu Wang, You-Jia Guo & Yan Li
Pages: 607-616
Published online: 13 Mar 2024
AbstractforAnalysis of drug-induced posterior reversible encephalopathy syndrome using the food and drug administration adverse drug events reporting system database | Full Text | References | PDF (3 MB) | EPUB
  • 35 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Weichui Zhang, Mianhai Chen, Xiaolin Cai, Mengting Zhang, Mianda Hu, Yanghui Hu, Yurong Yang, Jinfeng Zhu, Yikuan Du & Chun Yang
Pages: 617-625
Published online: 03 Apr 2024
AbstractforDetection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system | Full Text | References | PDF (3.9 MB) | EPUB
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Bruton’s tyrosine kinase inhibitors (BTKis) single and its combination therapy
Sichun Xiang, Rongbin Shen, Jingjing Xiang, Ni Zhu, Jianyou Gu, Jianping Shen, Yu Zhang & Hangping Ge
Pages: 627-636
Published online: 18 Mar 2024
AbstractforA real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Bruton’s tyrosine kinase inhibitors (BTKis) single and its combination therapy | Full Text | References | PDF (3.6 MB) | EPUB
  • 1003 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Post-marketing safety concerns with palbociclib: a disproportionality analysis of the FDA adverse event reporting system
Qian Cheng, Xuan Shi, Yazheng Zhao, Shupeng Zou & Minghui Sun
Pages: 637-648
Published online: 12 Apr 2024
AbstractforPost-marketing safety concerns with palbociclib: a disproportionality analysis of the FDA adverse event reporting system | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 101 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology
Vipin Bhati, Anoop Kumar, Viney Lather, Ruchika Sharma & Deepti Pandita
Pages: 649-658
Published online: 09 Nov 2023
AbstractforAssociation of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology | Full Text | References | PDF (5.2 MB) | EPUB | Supplemental
  • 142 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles